2000
Vascular drugs in the new millennium11No competing interests declared.
Frangos S, Chen A, Sumpio B. Vascular drugs in the new millennium11No competing interests declared. Journal Of The American College Of Surgeons 2000, 191: 76-92. PMID: 10898187, DOI: 10.1016/s1072-7515(00)00292-1.Peer-Reviewed Original ResearchAbciximabAnimalsAnistreplaseAntibodies, MonoclonalAnticoagulantsAspirinChondroitin SulfatesClopidogrelDermatan SulfateDrug CombinationsFibrinolytic AgentsHeparin, Low-Molecular-WeightHeparitin SulfateHumansImmunoglobulin Fab FragmentsIntermittent ClaudicationPlatelet Aggregation InhibitorsStreptokinaseTiclopidineVascular DiseasesVenous Thrombosis
1985
Reduction of the drug-induced nephrotoxicity by ATP-MgCl2. 1. Effects on the cis-Diamminedichloroplatinum-treated isolated perfused kidneys
Sumpio B, Chaudry I, Baue A. Reduction of the drug-induced nephrotoxicity by ATP-MgCl2. 1. Effects on the cis-Diamminedichloroplatinum-treated isolated perfused kidneys. Journal Of Surgical Research 1985, 38: 429-437. PMID: 3872963, DOI: 10.1016/0022-4804(85)90058-7.Peer-Reviewed Original ResearchConceptsAcute renal failureATP-MgCl2Hr of perfusionCis-DiamminedichloroplatinumNephrotoxic effectsReabsorptive capacityCDDP treatmentRat kidneyATP-MgCl2 treatmentIsolated rat kidneyDrug-induced nephrotoxicityDirect nephrotoxic effectNew therapeutic modalitiesProximal tubule cellsCancer chemotherapeutic agentsCDDP therapyRenal failureMarked diuresisProtein reabsorptionTherapeutic modalitiesTubule cellsChemotherapeutic agentsMicrograms/KidneyMarked inhibition